In this double-blind trial of 1,961 adults with a body mass index (BMI) of 30 or higher, adults on high dose 2.4 mg of weekly semaglutide (compared with the usual type 2 diabetes dose of 0.5mg or 1mg) lost an average 14.9% of baseline body weight after 68 weeks of treatment versus only 2.4% for a group on placebo and lifestyle intervention alone
Tables 5 and 6) (See Supplementary Material for Clinical Takeaways)
White adipose tissue (WAT) is the biggest mammalian triacylglycerol (TG) storage depot
AK: Conceptualization, Writing review & editing, Supervision, Writing original draft, Methodology
Injection sites rotate systematically across the abdomen, thighs, and upper arms, preventing lipohypertrophy (injection site fat accumulation) while maintaining comfortable subcutaneous access
This genetic insight transforms your compounded therapy from a standard protocol into a personalized strategy matched to your metabolic biology